Suppr超能文献

设计针对(-)-可卡因的人丁酰胆碱酯酶高活性突变体:影响催化效率的结构和能量因素。

Design of high-activity mutants of human butyrylcholinesterase against (-)-cocaine: structural and energetic factors affecting the catalytic efficiency.

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 South Limestone, Lexington, Kentucky 40536, United States.

出版信息

Biochemistry. 2010 Oct 26;49(42):9113-9. doi: 10.1021/bi1011628.

Abstract

The present study was aimed to explore the correlation between the protein structure and catalytic efficiency of butyrylcholinesterase (BChE) mutants against (-)-cocaine by modeling the rate-determining transition state (TS1), i.e., the transition state for the first step of chemical reaction process, of (-)-cocaine hydrolysis catalyzed by various mutants of human BChE in comparison with the wild type. Molecular modeling of the TS1 structures revealed that mutations on certain nonactive site residues can indirectly affect the catalytic efficiency of the enzyme against (-)-cocaine through enhancing or weakening the overall hydrogen bonding between the carbonyl oxygen of (-)-cocaine benzoyl ester and the oxyanion hole of the enzyme. Computational insights and predictions were supported by the catalytic activity data obtained from wet experimental tests on the mutants of human BChE, including five new mutants reported for the first time. The BChE mutants with at least ∼1000-fold improved catalytic efficiency against (-)-cocaine compared to the wild-type BChE are all associated with the TS1 structures having stronger overall hydrogen bonding between the carbonyl oxygen of (-)-cocaine benzoyl ester and the oxyanion hole of the enzyme. The combined computational and experimental data demonstrate a reasonable correlation relationship between the hydrogen-bonding distances in the TS1 structure and the catalytic efficiency of the enzyme against (-)-cocaine.

摘要

本研究旨在通过建模(-)-可卡因水解反应的第一步速率决定过渡态(TS1),即反应过渡态,探索丁酰胆碱酯酶(BChE)突变体的蛋白结构与对(-)-可卡因催化效率之间的相关性。与野生型相比,比较了各种人 BChE 突变体对(-)-可卡因水解的催化效率。TS1 结构的分子建模表明,某些非活性位点残基的突变可以通过增强或削弱(-)-可卡因苯甲酰酯羰基氧与酶的氧阴离子穴之间的整体氢键,间接地影响酶对(-)-可卡因的催化效率。计算结果和预测得到了人 BChE 突变体湿实验测试的催化活性数据的支持,其中包括首次报道的五个新突变体。与野生型 BChE 相比,对(-)-可卡因的催化效率至少提高了 1000 倍的 BChE 突变体都与 TS1 结构具有更强的整体氢键有关,(-)-可卡因苯甲酰酯羰基氧与酶的氧阴离子穴之间。综合计算和实验数据表明,TS1 结构中的氢键距离与酶对(-)-可卡因的催化效率之间存在合理的相关性。

相似文献

2
Computational redesign of human butyrylcholinesterase for anticocaine medication.
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16656-61. doi: 10.1073/pnas.0507332102. Epub 2005 Nov 7.
3
Catalytic activities of a cocaine hydrolase engineered from human butyrylcholinesterase against (+)- and (-)-cocaine.
Chem Biol Interact. 2013 Mar 25;203(1):57-62. doi: 10.1016/j.cbi.2012.08.003. Epub 2012 Aug 11.
7
Characterization of a high-activity mutant of human butyrylcholinesterase against (-)-cocaine.
Chem Biol Interact. 2010 Sep 6;187(1-3):148-52. doi: 10.1016/j.cbi.2010.01.004. Epub 2010 Jan 11.
8
Substrate selectivity of high-activity mutants of human butyrylcholinesterase.
Org Biomol Chem. 2013 Nov 21;11(43):7477-85. doi: 10.1039/c3ob41713a.
9
10
Rational design of an enzyme mutant for anti-cocaine therapeutics.
J Comput Aided Mol Des. 2008 Sep;22(9):661-71. doi: 10.1007/s10822-007-9144-9. Epub 2007 Nov 8.

引用本文的文献

2
Treatment of acute organophosphate poisoning by using a cocaine hydrolase engineered from human butyrylcholinesterase.
Chem Biol Interact. 2025 Aug 1;416:111552. doi: 10.1016/j.cbi.2025.111552. Epub 2025 May 8.
6
A Comprehensive Review of Cholinesterase Modeling and Simulation.
Biomolecules. 2021 Apr 15;11(4):580. doi: 10.3390/biom11040580.
9
Catalytic activities of cocaine hydrolases against the most toxic cocaine metabolite norcocaethylene.
Org Biomol Chem. 2020 Mar 11;18(10):1968-1977. doi: 10.1039/c9ob02762a.

本文引用的文献

1
Novel pharmacological approaches to treatment of drug overdose and addiction.
Expert Rev Clin Pharmacol. 2009;2(1):1-4. doi: 10.1586/17512433.2.1.1.
2
The concept of pharmacologic cocaine interception as a treatment for drug abuse.
Chem Biol Interact. 2010 Sep 6;187(1-3):421-4. doi: 10.1016/j.cbi.2010.02.036. Epub 2010 Feb 26.
4
A thermally stable form of bacterial cocaine esterase: a potential therapeutic agent for treatment of cocaine abuse.
Mol Pharmacol. 2010 Apr;77(4):593-600. doi: 10.1124/mol.109.060806. Epub 2010 Jan 19.
5
Characterization of a high-activity mutant of human butyrylcholinesterase against (-)-cocaine.
Chem Biol Interact. 2010 Sep 6;187(1-3):148-52. doi: 10.1016/j.cbi.2010.01.004. Epub 2010 Jan 11.
6
Cocaine esterase prevents cocaine-induced toxicity and the ongoing intravenous self-administration of cocaine in rats.
J Pharmacol Exp Ther. 2009 Nov;331(2):445-55. doi: 10.1124/jpet.108.150029. Epub 2009 Aug 26.
7
Free-energy perturbation simulation on transition states and redesign of butyrylcholinesterase.
Biophys J. 2009 Mar 4;96(5):1931-8. doi: 10.1016/j.bpj.2008.11.051.
8
Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity.
Mol Pharmacol. 2009 Feb;75(2):318-23. doi: 10.1124/mol.108.049486. Epub 2008 Nov 5.
9
Most efficient cocaine hydrolase designed by virtual screening of transition states.
J Am Chem Soc. 2008 Sep 10;130(36):12148-55. doi: 10.1021/ja803646t. Epub 2008 Aug 19.
10
A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats.
Neuropsychopharmacology. 2008 Oct;33(11):2715-25. doi: 10.1038/sj.npp.1301666. Epub 2008 Jan 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验